J. Russell Hoverman, MD, PhD


Authored Items

Impact of a Cancer Management Program

March 2013, Vol 4, No 3 - AVBCC 2013 3rd Annual Conference Abstracts

Background: US Oncology, Inc. and Aetna are engaged in a pilot program, Innovent Oncology (IOP) to evaluate clinical and financial impacts of Pathways (PW), a nursing call intervention for chemotherapy patients (patient support services [PSS]), and an advanced care planning (ACP) initiative. We report quality initiatives, PW compliance, and ACP, from the program at 18 months, and inpatient (IP) and emergency department admissions at 12 months.

[ Read More ]